Transcatheter aortic valve replacement (TAVR) is approved for all patient risk profiles and is
an option for all patients irrespective of age. However, patients enrolled in the low-and …

OBJECTIVES Transcatheter aortic valve replacement (TAVR) represents a valid treatment
for patients with aortic valve stenosis and high or intermediate surgical risk. However …

Background: Coronary artery obstruction is a rare, devastating complication of transcatheter
aortic valve replacement. Transcatheter electrosurgical aortic leaflet laceration …

Background: The supra-annular leaflet position and tall stent frame of the self-expanding
Evolut PRO or Evolut PRO+ transcatheter heart valves (THVs) may cause coronary …

BASILICA (bioprosthetic aortic scallop intentional laceration to prevent coronary artery
obstruction) can prevent coronary obstruction following transcatheter aortic valve …

Background Transcatheter aortic valve implantation in an existing transcatheter valve (redo-
TAVI) pins the index valve leaflets in the open position (neoskirt), which can cause coronary …

Objectives The aims of this study were to determine the rate of noncentered coronary ostia
and their risk for coronary overlap (CO) and to develop an improved orientation strategy for …

Objectives The aim of this study was to examine real-world experience with repeat
transcatheter aortic valve replacement (TAVR) in a population-based national database …

BACKGROUND: Our aim was to assess the feasibility of repeat transcatheter aortic valve
(TAV) replacement for degenerated Sapien3 (S3) prostheses by simulating subsequent …

Objectives We assessed the impact of conventional delivery system (DS) insertion technique
on “Hat‐marker” orientation/commissural alignment in patients who underwent transcatheter …